Related Experiment Video
Updated: May 6, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents
Irfana Muqbil1, Ashiq Masood, Fazlul H Sarkar
1Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202002, UP, India. azmia@karmanos.org.
Abstract:
Cancer chemoprevention is defined as the use of natural agents to suppress, reverse or prevent the carcinogenic process from turning into aggressive cancer. Over the last two decades, multiple natural dietary compounds with diverse chemical structures such flavonoids, tannins, curcumins and polyphenols have been proposed as chemopreventive agents. These agents have proven excellent anticancer potential in the laboratory setting, however, the observed effects in vitro do not translate in clinic where they fail to live up to their expectations. Among the various reasons for this discrepancy include inefficient systemic delivery and robust bioavailability. To overcome this barrier, researchers have focused towards coupling these agents with nano based encapsulation technology that in principle will enhance bioavailability and ultimately benefit clinical outcome. The last decade has witnessed rapid advancement in the development of nanochemopreventive technology with emergence of many nano encapsulated formulations of different dietary anticancer agents. This review summarizes the most up-to-date knowledge on the studies performed in nanochemoprevention, their proposed use in the clinic and future directions in which this field is heading. As the knowledge of the dynamics of nano encapsulation evolves, it is expected that researchers will bring forward newer and far more superior nanochemopreventive agents that may become standard drugs for different cancers.
Insights
Natural compounds show promise for cancer chemoprevention, but poor bioavailability limits clinical success. Nanotechnology enhances delivery, improving potential cancer treatments.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Natural dietary compounds like flavonoids and polyphenols exhibit anticancer properties in laboratory studies.
- Clinical efficacy of these agents is often limited by poor systemic delivery and bioavailability.
- Nanotechnology offers a promising solution to enhance the delivery and effectiveness of chemopreventive agents.
Purpose of the Study:
- To review the advancements in nanochemoprevention technology.
- To summarize current research on nano-encapsulated dietary anticancer agents.
- To discuss the clinical applications and future directions of nanochemoprevention.
Main Methods:
- Review of recent scientific literature on nanochemoprevention.
- Analysis of studies on nano-encapsulated natural dietary compounds.
- Synthesis of data on bioavailability and clinical outcomes.
Main Results:
- Nanochemoprevention significantly enhances the bioavailability of natural anticancer agents.
- Nano-encapsulation overcomes delivery barriers, improving therapeutic potential.
- Numerous nano-formulations of dietary compounds have been developed.
Conclusions:
- Nanochemoprevention represents a significant advancement in cancer chemoprevention.
- Further development is expected to yield superior nanochemopreventive agents for clinical use.
- This field holds promise for developing new standard cancer treatments.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microbial Corrosion
Pharmacogenomics: Identification of New Drug Targets
Mutagenicity and Carcinogenicity
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

